ANDA 91164, held by Cipla. Anastrozole.
As of Nov 16, 2026, ANDA 91164 (Anastrozole), held by Cipla, was first approved by FDA on Jun 28, 2010, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Anastrozole1MG · tablet;oral | Anastrozole | Rx |
| Feb 18, 2025 | Supplement 3Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 2Labeling · Standard review | Approved | None posted |
| Oct 22, 2016 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jun 28, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters